ClinVar Miner

Submissions for variant NM_001277115.2(DNAH11):c.3384C>T (p.Ser1128=)

gnomAD frequency: 0.00235  dbSNP: rs79955190
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000205811 SCV000262503 benign Primary ciliary dyskinesia 2024-01-31 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV000244962 SCV000307492 benign not specified criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000205811 SCV000468082 uncertain significance Primary ciliary dyskinesia 2016-06-14 criteria provided, single submitter clinical testing
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000244962 SCV000711297 benign not specified 2013-02-21 criteria provided, single submitter clinical testing Ser1128Ser in exon 17 of DNAH11: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 0.6% (24/3712) of African American chromosomes from a broad population by the NHLBI Exome Sequenc ing Project (http://evs.gs.washington.edu/EVS; dbSNP rs79955190).
CeGaT Center for Human Genetics Tuebingen RCV003437007 SCV004163785 likely benign not provided 2023-08-01 criteria provided, single submitter clinical testing DNAH11: BP4, BP7

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.